Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss

被引:43
作者
Flight, Simone M. [1 ]
Johnson, Lambro A. [1 ]
Du, Qianyun S. [1 ]
Warner, Roscoe L. [2 ]
Trabi, Manuela [3 ,4 ]
Gaffney, Patrick J. [5 ]
Lavin, Martin F. [4 ,6 ]
de Jersey, John [3 ]
Masci, Paul P. [1 ]
机构
[1] Univ Queensland, Sch Med, Brisbane, Qld, Australia
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Univ Queensland, Sch Chem & Mol Biosci Chem & Mol Biosci, Brisbane, Qld, Australia
[4] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
[5] St Thomas Hosp, Acad Dept Surg, London, England
[6] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
textilinin-1; aprotinin; serine protease inhibitor; anti-bleeding; anti-fibrinolytic; ANAPHYLACTIC REACTION; BYPASS;
D O I
10.1111/j.1365-2141.2009.07605.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aprotinin has been used widely in surgery as an anti-bleeding agent but is associated with a number of side effects. We report that textilinin-1, a serine protease inhibitor from Pseudonaja textilis venom with sequence relatedness to aprotinin, is a potent but reversible plasmin inhibitor and has a narrower range of protease inhibition compared to aprotinin. Like aprotinin, textilinin-1 at 5 mu mol/l gave almost complete inhibition of tissue plasminogen activator-induced fibrinolysis of whole blood clots. The activated partial thromboplastin time for plasma was markedly increased by aprotinin but unaffected by textilinin-1. In a mouse tail-vein bleeding model, intravenous textilinin-1 and aprotinin caused similar decreases in blood loss but time to haemostasis in the textilinin-treated animals was significantly shorter than in aprotinin-treated mice. Based on these data, textilinin-1 merits further investigation as a therapeutic alternative to aprotinin.
引用
收藏
页码:207 / 211
页数:5
相关论文
共 25 条
  • [1] [Anonymous], LAB MANUAL BLOOD COA
  • [2] Forty years of clinical aprotinin use: A review of 124 hypersensitivity reactions
    Beierlein, W
    Scheule, AM
    Dietrich, W
    Ziemer, G
    [J]. ANNALS OF THORACIC SURGERY, 2005, 79 (02) : 741 - 748
  • [3] Severe anaphylactic reaction after primary exposure to aprotinin
    Cohen, DM
    Norberto, J
    Cartabuke, R
    Ryu, G
    [J]. ANNALS OF THORACIC SURGERY, 1999, 67 (03) : 837 - 838
  • [4] Colman R. W., 2006, Hemostasis and thrombosis: basic principles and clinical practice
  • [5] Review and application of serine protease inhibition in coronary artery bypass graft surgery
    Engles, L
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 : S9 - S14
  • [6] Espana F., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P119, DOI 10.2174/1568016053544336
  • [7] A comparison of aprotinin and lysine analogues in high-risk cardiac surgery
    Fergusson, Dean A.
    Hebert, Paul C.
    Mazer, C. David
    Fremes, Stephen
    MacAdams, Charles
    Murkin, John M.
    Teoh, Kevin
    Duke, Peter C.
    Arellano, Ramiro
    Blajchman, Morris A.
    Bussieres, Jean S.
    Cote, Dany
    Karski, Jacek
    Martineau, Raymond
    Robblee, James A.
    Rodger, Marc
    Wells, George
    Clinch, Jennifer
    Pretorius, Roanda
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (22) : 2319 - 2331
  • [8] A family of textilinin genes, two of which encode proteins with antihaemorrhagic properties
    Filippovich, I
    Sorokina, N
    Masci, PP
    de Jersey, J
    Whitaker, AN
    Winzor, DJ
    Gaffney, PJ
    Lavin, MF
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (02) : 376 - 384
  • [9] Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents
    Flight, Simone
    Johnson, Lambro
    Trabi, Manuela
    Gaffney, Patrick
    Lavin, Martin
    de Jersey, John
    Masci, Paul
    [J]. PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2005, 34 (4-5) : 188 - 193
  • [10] Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial
    Hekmat, K
    Zimmermann, T
    Kampe, S
    Kasper, SM
    Weber, HJ
    Geissler, HJ
    Mehlhorn, U
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (01) : 121 - 126